首页 正文

RESEARCH ADVANCES IN NEUROBLASTOMA IMMUNOTHERAPY

{{output}}
Neuroblastoma is the third most common pediatric cancer in the United States and is responsible for 15% of pediatric cancer-related deaths. Despite major advances in multimodal therapy, the clinical outcome for several patients remains poor. Due to the despera... ...